Pricing Log in Create free account

Heatwurx Inc. (PCSA) vs Pulmatrix, Inc. (PULM)

Heatwurx Inc. and Pulmatrix, Inc. are both Biotechnology companies. Heatwurx Inc. and Pulmatrix, Inc. are of similar size ($5.2M and $4.7M). Pulmatrix, Inc. has negative trailing earnings, so its P/E is not meaningful; Heatwurx Inc. trades at 1.6×. Pulmatrix, Inc. grew revenue faster over the last twelve months: 6.96% against −34.5%. Across the 11 metrics below, Pulmatrix, Inc. leads on 8 and Heatwurx Inc. on 3.

Valuation

Metric PCSA PULM Biotechnology median
P/E 1.61 n/m 8.50
P/S 35.49 0.64 9.71
P/B n/m 3.12 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 45.29 0.82 9.21
Earnings yield 62.21% (80.88%) (33.15%)
Free cash flow yield (282.73%) (86.74%) (25.50%)

Profitability

Metric PCSA PULM Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (464.19%) (111.99%) (56.36%)
Return on assets (262.17%) (85.74%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric PCSA PULM Biotechnology median
Revenue growth (TTM) (34.50%) 6.96% 6.02%
EPS growth (last fiscal year) 89.29% 46.18% 30.26%
Revenue growth, 5-year CAGR — (0.26%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PCSA PULM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.87 4.70 4.72
Net debt to EBITDA 0.40 0.79 0.96

Dividend

Metric PCSA PULM Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PCSA PULM Biotechnology median
Market cap 4.70m 5.15m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack